| Melatonin | IC50 | 2.2 [1] |
| Melatonin | Ki | 0.08 [1], 1.1 [2] |
| 6-Chloromelatonin | IC50 | 0.04 [1], 3.6 [2] |
| 6-Chloromelatonin | Ki | 0.99 [1], 2.2 [2] |
| N-[2-(5-Methoxy-2-phenyl-1H-indol-3-yl)ethyl]acetamide | IC50 | 0.06 [1] |
| N-[2-(5-Methoxy-2-phenyl-1H-indol-3-yl)ethyl]acetamide | Ki | 0.02 [1], 0.06 [2] |
| N-(2-(2-Bromo-5-methoxy-1H-indol-3-yl)ethyl)acetamide | IC50 | 0.13 [1] |
| N-(2-(2-Bromo-5-methoxy-1H-indol-3-yl)ethyl)acetamide | Ki | 0.04 [1], 0.06 [2] |
| N-[2-(6-Methoxy-2-phenylindol-1-yl)ethyl]propanamide | IC50 | 0.05 [1], 0.19 [2], 1.18 [3] |
| N-[2-(6-Methoxy-2-phenylindol-1-yl)ethyl]propanamide | Ki | 0.01 [1] |
| N-[2-(5-Methoxyindol-1-yl)ethyl]propanamide | IC50 | 5400.0 [1], 10400.0 [2], 10500.0 [3] |
| N-[2-(5-Methoxyindol-1-yl)ethyl]propanamide | Ki | 1500.0 [1] |
| N-(2-Bromo-6-methoxy-1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)acetamide | IC50 | 73.0 [1], 89.5 [2], 396.0 [3] |
| N-(2-Bromo-6-methoxy-1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)acetamide | Ki | 20.0 [1] |
| N-(6-Methoxy-1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)acetamide | IC50 | 1200.0 [1], 3110.0 [2], 8970.0 [3] |
| N-(6-Methoxy-1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)acetamide | Ki | 330.0 [1] |
| CID 44303129 | IC50 | 1.07 [1], 1.4 [2], 2.99 [3] |
| CID 44303129 | Ki | 0.39 [1] |
| N-(2-Indol-1-ylethyl)cyclopropanecarboxamide | IC50 | 2250.0 [1], 3200.0 [2], 5700.0 [3] |
| N-(2-Indol-1-ylethyl)cyclopropanecarboxamide | Ki | 880.0 [1] |
| Agomelatine | IC50 | 0.08 [1] |
| Agomelatine | Ki | 0.1 [1] |
| 2-Iodomelatonin | IC50 | 0.01 [1] |
| 2-Iodomelatonin | Ki | 0.02 [1] |
| 5-Hydroxyethoxy-N-acetyltryptamine | IC50 | 1020.0 [1] |
| 5-Hydroxyethoxy-N-acetyltryptamine | Ki | 289.0 [1] |
| 3-Acetylaminocarbazole | IC50 | 3000.0 [1] |
| 3-Acetylaminocarbazole | Ki | 820.0 [1] |
| N-[2-(5-Methoxy-1-methyl-1H-indol-3-yl)-ethyl]-acetamide | IC50 | 25.5 [1] |
| N-[2-(5-Methoxy-1-methyl-1H-indol-3-yl)-ethyl]-acetamide | Ki | 6.72 [1] |
| 6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carbolin-1-one | IC50 | 33000.0 [1] |
| 6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carbolin-1-one | Ki | 9100.0 [1] |
| N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]cyclopropanecarboxamide | IC50 | 0.0 [1] |
| N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]cyclopropanecarboxamide | Ki | 2.2 [1] |
| N-[2-(2-Phenyl-1H-indol-3-yl)ethyl]cyclobutanecarboxamide | IC50 | 7100.0 [1] |
| N-[2-(2-Phenyl-1H-indol-3-yl)ethyl]cyclobutanecarboxamide | Ki | 1900.0 [1] |
| Ethyl 3-(acetamidomethyl)-6-methoxy-1,3,4,5-tetrahydrobenzo[cd]indole-2-carboxylate | IC50 | 1.7 [1] |
| Ethyl 3-(acetamidomethyl)-6-methoxy-1,3,4,5-tetrahydrobenzo[cd]indole-2-carboxylate | Ki | 0.48 [1] |
| N-[2-(2-Bromo-6-methoxyindol-1-yl)ethyl]propanamide | IC50 | 0.16 [1] |
| N-[2-(2-Bromo-6-methoxyindol-1-yl)ethyl]propanamide | Ki | 0.04 [1] |
| N-[2-(6-Methoxyindol-1-yl)ethyl]propanamide | IC50 | 7.1 [1] |
| N-[2-(6-Methoxyindol-1-yl)ethyl]propanamide | Ki | 1.9 [1] |
| N-[2-(1-Benzyl-5-methoxyindol-3-yl)ethyl]acetamide | IC50 | 1090.0 [1] |
| N-[2-(1-Benzyl-5-methoxyindol-3-yl)ethyl]acetamide | Ki | 287.0 [1] |
| N-Acetyl-6-methoxytryptamine | IC50 | 4800.0 [1] |
| N-Acetyl-6-methoxytryptamine | Ki | 1180.0 [1] |
| 6-Methoxy-1-[2-(acetylamino)ethyl]-1H-benzimidazole | IC50 | 5260.0 [1] |
| 6-Methoxy-1-[2-(acetylamino)ethyl]-1H-benzimidazole | Ki | 5000.0 [1] |
| N-[2-(5-Methoxy-1-phenylindol-3-yl)ethyl]acetamide | IC50 | 1470.0 [1] |
| N-[2-(5-Methoxy-1-phenylindol-3-yl)ethyl]acetamide | Ki | 380.0 [1] |
| N-[2-(2-Phenylindol-1-yl)ethyl]propanamide | IC50 | 82.0 [1] |
| N-[2-(2-Phenylindol-1-yl)ethyl]propanamide | Ki | 23.0 [1] |
| N-[2-(4,5,6-Trimethoxy-1H-indol-3-yl)ethyl]acetamide | IC50 | 2460.0 [1] |
| N-[2-(4,5,6-Trimethoxy-1H-indol-3-yl)ethyl]acetamide | Ki | 617.0 [1] |
| 6-Methoxy-1-[2-(propionylamino)ethyl]-1H-indole-2-carboxylic acid methyl ester | IC50 | 0.83 [1] |
| 6-Methoxy-1-[2-(propionylamino)ethyl]-1H-indole-2-carboxylic acid methyl ester | Ki | 0.23 [1] |
| N-[2-(6-Methoxyindol-1-yl)ethyl]acetamide | IC50 | 12.0 [1] |
| N-[2-(6-Methoxyindol-1-yl)ethyl]acetamide | Ki | 3.4 [1] |
| N-[2-(5-Methoxy-1H-indol-4-yl)ethyl]acetamide | IC50 | 1300.0 [1] |
| N-[2-(5-Methoxy-1H-indol-4-yl)ethyl]acetamide | Ki | 360.0 [1] |
| N-[2-(5,7-Dimethoxy-1H-indol-3-yl)ethyl]acetamide | IC50 | 491.0 [1] |
| N-[2-(5,7-Dimethoxy-1H-indol-3-yl)ethyl]acetamide | Ki | 121.0 [1] |
| N-[(6-Methoxy-1,3,4,5-tetrahydrobenzo[cd]indol-3-yl)methyl]acetamide | IC50 | 9.9 [1] |
| N-[(6-Methoxy-1,3,4,5-tetrahydrobenzo[cd]indol-3-yl)methyl]acetamide | Ki | 2.7 [1] |
| 3-(Acetylamino)-6-methoxy-9H-carbazole | IC50 | 230.0 [1] |
| 3-(Acetylamino)-6-methoxy-9H-carbazole | Ki | 63.0 [1] |
| Propanamide,n-[2-(2-iodo-5-methoxy-1h-indol-1-yl)ethyl]- | IC50 | 360.0 [1] |
| Propanamide,n-[2-(2-iodo-5-methoxy-1h-indol-1-yl)ethyl]- | Ki | 99.0 [1] |
| N-[2-(5-Chloro-1H-indol-3-yl)ethyl]acetamide | IC50 | 126.0 [1] |
| N-[2-(5-Chloro-1H-indol-3-yl)ethyl]acetamide | Ki | 30.0 [1] |
| N-[2-(7-Methoxy-1H-indol-3-yl)ethyl]acetamide | IC50 | 2620.0 [1] |
| N-[2-(7-Methoxy-1H-indol-3-yl)ethyl]acetamide | Ki | 647.0 [1] |
| N-[2-(5-Bromo-1H-indol-3-yl)ethyl]acetamide | IC50 | 33.6 [1] |
| N-[2-(5-Bromo-1H-indol-3-yl)ethyl]acetamide | Ki | 8.91 [1] |
| N-[2-(4-Methoxy-1H-indol-3-yl)ethyl]acetamide | IC50 | 772.0 [1] |
| N-[2-(4-Methoxy-1H-indol-3-yl)ethyl]acetamide | Ki | 190.0 [1] |
| CID 44303043 | IC50 | 29.0 [1] |
| CID 44303043 | Ki | 8.0 [1] |
| N-[2-(5-Fluoro-1H-indol-3-yl)ethyl]acetamide | IC50 | 295.0 [1] |
| N-[2-(5-Fluoro-1H-indol-3-yl)ethyl]acetamide | Ki | 72.8 [1] |
| N-[2-(5-Methyl-1H-indol-3-yl)ethyl]acetamide | IC50 | 719.0 [1] |
| N-[2-(5-Methyl-1H-indol-3-yl)ethyl]acetamide | Ki | 180.0 [1] |
| N-(2-Indol-1-ylethyl)cyclobutanecarboxamide | IC50 | 18000.0 [1] |
| N-(2-Indol-1-ylethyl)cyclobutanecarboxamide | Ki | 5000.0 [1] |
| 2,2,2-Trifluoro-N-[2-(6-methoxyindol-1-yl)ethyl]acetamide | IC50 | 35.0 [1] |
| 2,2,2-Trifluoro-N-[2-(6-methoxyindol-1-yl)ethyl]acetamide | Ki | 9.6 [1] |
| N-[2-(2,4-Dibromo-5-methoxy-1H-indol-3-yl)ethyl]acetamide | IC50 | 23.3 [1] |
| N-[2-(2,4-Dibromo-5-methoxy-1H-indol-3-yl)ethyl]acetamide | Ki | 5.75 [1] |
| N-[2-(2-Phenylindol-1-yl)ethyl]cyclobutanecarboxamide | IC50 | 10000.0 [1] |
| N-[2-(2-Phenylindol-1-yl)ethyl]cyclobutanecarboxamide | Ki | 2800.0 [1] |
| 6-Methoxy-1-[3-(propionylamino)propyl]-1H-indole-2-carboxylic acid methyl ester | IC50 | 4.8 [1] |
| 6-Methoxy-1-[3-(propionylamino)propyl]-1H-indole-2-carboxylic acid methyl ester | Ki | 1.3 [1] |
| N-[2-(6-Methoxyindol-1-yl)ethyl]butanamide | IC50 | 11.0 [1] |
| N-[2-(6-Methoxyindol-1-yl)ethyl]butanamide | Ki | 3.0 [1] |
| N-[2-(6-Methoxyindol-1-yl)ethyl]cyclopropanecarboxamide | IC50 | 89.0 [1] |
| N-[2-(6-Methoxyindol-1-yl)ethyl]cyclopropanecarboxamide | Ki | 24.0 [1] |
| (4Ar,9bS)-7-chloro-8-methoxy-2,3,4,4a,5,9b-hexahydro-1H-indeno[1,2-b]pyridine | Ki | 10000.0 [1] |
| 1-[(4Ar,9bS)-7-chloro-8-methoxy-2,3,4,4a,5,9b-hexahydroindeno[1,2-b]pyridin-1-yl]ethanone | Ki | 10000.0 [1] |
| (4Ar,9bS)-7-chloro-N-ethyl-8-methoxy-2,3,4,4a,5,9b-hexahydroindeno[1,2-b]pyridine-1-carboxamide | Ki | 190.0 [1], 670.0 [2] |
| (2S,7R)-12,14-Dioxa-3-azatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),9,11(15)-triene | Ki | 10000.0 [1] |